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Objective	Both	depression	itself	and	antidepressant	medication	have	been	reported	to	be	significantly	related	to	the	risk	of	 type	2	diabetes	mellitus	(T2DM).	Glucagon-like	peptide-1	(GLP-1),	a	 treatment	target	for	T2DM,	has	a	neuroprotective	effect.	As	an	enhancer	and	sensitiser	of	GLP-1,	metformin	has	been	reported	to	be	safe	for	the	neurodevelopment.	The	present	study	aimed	to	determine	whether	and	how	GLP-1	mediates	antidepressant	effects	of	metformin	and	exercise	in	mice.	
Methods	Male	C57BL/6	mice	were	exposed	to	chronic	unpredictable	mild	stress	(CUMS)	for	8	weeks.	From	the	4th	week,	CUMS	mice	were	subjected	to	oral	metformin	treatment	and/or	treadmill	running.	A	videocomputerized	tracking	system	was	used	to	record	behaviors	of	mice	for	a	5-min	session.	ELISA,	western	blotting	and	immunohistochemistry	were	used	to	examine	gene	expression	in	mouse	serum	or	hippocampus.	
Results	 Our	 results	 supported	 the	 validity	 of	 metformin	 as	 a	 useful	 antidepressant;	 moreover,	treadmill	 running	 favored	 metformin	 effects	 on	 exploratory	 behaviors	 and	 serum	 corticosterone	levels.	CUMS	reduced	GLP-1	protein	levels	and	phosphorylation	levels	of	extracellular	signal-regulated	kinase	1/2	(ERK1/2),	but	increased	protein	levels	of	B-cell	lymphoma	2-associated	X-protein	(BAX)	in	mice	 hippocampus.	 All	 these	 changes	were	 restored	 by	 both	 single	and	 combined	 treatment	 with	metformin	and	exercise.	
Conclusions	Our	findings	have	demonstrated	that	ERK-BAX	signaling	is	involved	in	GLP-1-mediated	antidepressant	effects	of	metformin	and	exercise,	which	may	provide	a	novel	topic	for	future	clinical	research.	 	
